Trials / Conditions / Newly Diagnosed Acute Myeloid Leukemia (AML)
Newly Diagnosed Acute Myeloid Leukemia (AML)
5 registered clinical trials studyying Newly Diagnosed Acute Myeloid Leukemia (AML) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML NCT07172204 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemi NCT07514936 | Chinese PLA General Hospital | Phase 2 |
| Recruiting | SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) NCT05445154 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untre NCT03173248 | Institut de Recherches Internationales Servier | Phase 3 |
| Active Not Recruiting | Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With NCT02632708 | Institut de Recherches Internationales Servier | Phase 1 |